Specialized cystic fibrosis research and treatment development including CFTR modulators and supportive care therapies. This segment focuses on improving quality of life for CF patients.

Diverse therapeutic area research and development including emerging disease areas and novel treatment approaches. This segment explores new opportunities in healthcare innovation.